Kidney stone formation may be caused by a deficiency of inhibitors usually present in urine (1). Inhibitors reported in urine are magnesium, zinc, fluoride, stannous ion, citrate, pyrophosphate, phosphocitrate, RNA, and acidic glycoprotein (2). This paper presents the findings of reduced inhibitory capacity in urine of stone patients as compared to that in urine of normal subjects.
KeywordsUrine Sample Crystal Growth Medical College Hospital Inhibitory Capacity Acidic Glycoprotein
- 1.N Garti, F Tibika, S Sarig, and S Perlberg, in: “Urolithiasis, Clinical and Basic Research”, LH Smith, WG Robertson, and B Finlayson, eds., Plenum Press, New York (1981).Google Scholar
- 3.B Fellstrom, BG Danielson, FA Karlsson, and S Ljunghall, in: “Urolithiasis and Related Clinical Research”, PO Schwille, LH Smith, WG Robertson, and W Vahlensieck, eds., Plenum Press, New York (1985).Google Scholar